ConductScience.org, home
Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
API referenceFor AI assistants

Trial · NCT02113982

Participant flow168

How many started, completed or left each group, period by period.

1 to 20 of 168

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Stage 1: Dose EscalationSTARTEDStage 1 - AML Indication: 7 µg/kg/Day Dosage3
Stage 1: Dose EscalationSTARTEDStage 1 - AML Indication: 9 µg/kg/Day Dosage3
Stage 1: Dose EscalationSTARTEDStage 1 - AML Indication: 12 µg/kg/Day Dosage2
Stage 1: Dose EscalationSTARTEDStage 1 - AML Indication: 16 µg/kg/Day Dosage6
Stage 1: Dose EscalationSTARTED1L - Stage 1 - BPDCN Indication: 7 µg/kg/Day Dosage3
Stage 1: Dose EscalationSTARTED1L - Stage 1 - BPDCN Indication: 12 µg/kg/Day Dosage3
Stage 1: Dose EscalationSTARTEDR/R - Stage 1 - BPDCN Indication: 12 µg/kg/Day Dosage3
Stage 1: Dose EscalationSTARTEDStage 2 - AML Indication: 12 µg/kg/Day Dosage0
Stage 1: Dose EscalationSTARTEDStage 2 - AML Indication: 16 µg/kg/Day Dosage0
Stage 1: Dose EscalationSTARTED1L - Stage 2 - BPDCN Indication: 12 µg/kg/Day Dosage0
Stage 1: Dose EscalationSTARTEDR/R - Stage 2 - BPDCN Indication: 12 µg/kg/Day Dosage0
Stage 1: Dose EscalationSTARTED1L - Stage 3 - BPDCN Indication: 12 µg/kg/Day Dosage0
Stage 1: Dose EscalationSTARTED1L - Stage 4 - BPDCN Indication: 12 µg/kg/Day Dosage0
Stage 1: Dose EscalationSTARTEDR/R - Stage 4 - BPDCN Indication: 12 µg/kg/Day Dosage0
Stage 1: Dose EscalationCOMPLETEDStage 1 - AML Indication: 7 µg/kg/Day Dosage0
Stage 1: Dose EscalationCOMPLETEDStage 1 - AML Indication: 9 µg/kg/Day Dosage0
Stage 1: Dose EscalationCOMPLETEDStage 1 - AML Indication: 12 µg/kg/Day Dosage0
Stage 1: Dose EscalationCOMPLETEDStage 1 - AML Indication: 16 µg/kg/Day Dosage0
Stage 1: Dose EscalationCOMPLETED1L - Stage 1 - BPDCN Indication: 7 µg/kg/Day Dosage0
Stage 1: Dose EscalationCOMPLETED1L - Stage 1 - BPDCN Indication: 12 µg/kg/Day Dosage0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02113982/flow

API referenceFor AI assistants